ArticleProceedings of the National Academy of Sciences of the United States of America2018

Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti-PD-L1 to eliminate melanoma in mice.

Ying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.